Research and Markets has announced the addition of the "World
Ablation Technologies Market - Opportunities and Forecasts, 2014 - 2022"
report to their offering.
Rising incidences of symptoms such
as cancer and cardiac ailments is expected to foster the demand for
ablation procedures. Technological advancements to design high-end
products and growing demand for treatment procedures, which are
minimally invasive are expected to boost the ablation technologies
market. Furthermore, rising count of aging population having higher risk
of target diseases is another vital factor driving the demand for
ablation procedures.
However, measures taken by government to control healthcare cost are
along with current healthcare reforms in the U.S. may hamper the growth
of the market. Moreover, product recalls by companies will hinder the
growth of the market. Rising demand of emerging markets along with
increasing funding for design of novel ablation devices create abundant
growth opportunities to the market. Stringent regulatory framework
leading to an increase in the gestation period for product launches is a
key market challenge.
The market is segmented on the basis of
product, type, application and region. On the basis of type, the market
is segmented into light/laser, radiofrequency, electrical, ultrasound,
hydromechanical, cryoablation, microwave and hydrothermal. On the basis
of products, the market is segmented into laser/light ablators,
radiofrequency ablators, ultrasound ablators, radiofrequency ablators,
ultrasound ablators, electrical ablators, cryoablation devices,
microwave ablators and hydrothermal ablators.
The Laser/Light ablators is further segmented into excimer laser
ablators and cold laser ablators, where the former is further segmented
into ultraviolet B laser ablators. The radiofrequency ablators is
further segmented into temperature-controlled radiofrequency ablators,
fluid-cooled radiofrequency ablators, robotic catheter manipulation
systems.
The ultrasound ablators is further segmented into high-intensity focused
ultrasound ablators, magnetic resonance-guided focused ultrasound
ablators, ultrasonic surgical ablation systems, extracorporeal shockwave
lithotripsy systems while electrical ablators is further segmented into
argon plasma/beam coagulators and irreversible electroporation ablators.
The cryoablation devices is further segmented into tissue contact probes
and epidermal and subcutaneous cryoablation devices.
On the
basis of application, the market is segmented into general surgery,
cardiovascular surgery, cancer, ophthalmology, gynecology, urology,
orthopedics, cosmetic surgery and others where the cancer market is
further segmented into liver cancer, kidney cancer, prostate cancer,
lung cancer, and bone metastasis.
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
-
Middle East & Africa (LAMEA).
Key market players
- Covidien PLC
- Medtronic, Inc
- Biosense Webster, Inc
- St. Jude Medical, Inc
- Boston Scientific Corporation
- Angiodynamics, Inc
- Atricure, Inc
- Conmed Corporation
- Olympus Corporation
- Smith & Nephew PLC
For more information about this report visit http://www.researchandmarkets.com/research/mqsp3j/world_ablation
View source version on businesswire.com: http://www.businesswire.com/news/home/20170125005447/en/